United Kingdom, 26th Apr 2025 – The European Union (EU) has designated the pet healthcare industry as a strategic export sector and is launching a full-scale export expansion policy covering 12 high-value items, including animal formulas. This initiative responds to growing global demand for functional pet products made in Europe and is expected to accelerate the international expansion of R&D-driven life science companies.
The EU Commission stated, “Animal formulas are a prime example of the shift from treatment-based veterinary prescriptions to preventive daily care,” adding that this category is driving demand as a substitute for pharmaceuticals and is a key sector with strong export competitiveness.
High-functionality formulas take root as daily treatment alternatives
According to a recent report released by the European Commission, animal formulas have posted an average annual export growth rate of 21 percent over the past five years, marking the highest growth among functional product categories replacing pharmaceuticals. Preventive formulas targeting immune health, joint and liver function, and aging have become widely prescribed through veterinary networks and are rapidly gaining traction in North America and Asia.
The report concluded that animal formulas have established themselves within the life sciences sector through a structural approach that focuses on prevention before risk rather than treatment after symptoms.
Technology-driven European companies pursue differentiation with life-stage based products
One of the companies drawing attention under this export policy is Loyal Hound & Co., a UK-based pet life science company. Loyal Hound is noted for going beyond simple nutritional supplements by predicting disease risk across life stages and offering age-specific comprehensive formulas, positioning itself as a longevity-focused technology company.
A report by the European Parliament stated, “High-tech companies like Loyal Hound are evolving from functional supplement suppliers into big-data-driven life management solution providers, aligning with the EU’s strategic export priorities.”
Eleven additional products designated—ushering in a new era of comprehensive pet healthcare exports
In addition to animal formulas, the EU has added 11 more pet healthcare products to its strategic export list, including antioxidant treats, oral care sticks, hair and skin care oils, and functional aroma diffusers for stress relief.
As a result, the traditional export structure centered on pet food and toys is being restructured around high-functionality and science-driven product lines, opening up new global expansion opportunities for technology-based companies.
As of 2025, Loyal Hound is expanding its age-specific formula product line into Asian and Middle Eastern markets in line with the EU’s export strategy and is also implementing a localization strategy based on life expectancy data for each country.
A new era of life science trade led by technology
This export strategy carries significance beyond simple market expansion. The EU is clearly positioning European technology-based pet healthcare products as a next-generation export industry that addresses the aging pet population, long-term safety demands, and the need for early disease detection.
An EU Commission representative stated, “The pet industry is no longer an emotional consumer market. We have entered an era in which science and technology design lifespans—and that technology is now the foundation of export competitiveness.”
For More Information visit at Loyal Hound & Co. website.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No journalist was involved in the writing and production of this article.